Sarah Pope Miksinski
Gilead Sciences, Inc.
Appearances
DateJuly 15, 2021Join Roundtables & ICH Quality Guidelines Panel Discussion [https://live.remo…Panel Members
MEB-Medical Evaluations BoardSwedish Medical Products AgencyHealth CanadaSeqirus, A CSL CompanyPfizer, Inc.Gilead Sciences, Inc.Session Speaker
Eli Lilly and Company
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
DateSeptember 19, 2023TUESDAY, 19 SEPTEMBER 2023 - SESSION II: Pathway to Optimizing Submission and Review of CMC Post-Approval Changes: Employing Scientific Risk-Based Principles, Reliance Pathways, Adoption of WHO Post-Approval Guidelines, and Collaborative AssessmentsSpeakers
Seagen Inc.DIGEMID-General Directorate of Medicines, Supplies and DrugsGilead Sciences, Inc.SanofiSanofiDIGEMID-General Directorate of Medicines, Supplies and DrugsThis product is only available to members of the following groups:
- Members
